Company Filing History:
Years Active: 2021-2023
Title: Innovations of Likai Zhou
Introduction
Likai Zhou is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that act as kinase inhibitors. With a total of 4 patents to his name, Zhou's work is recognized for its potential impact on drug development.
Latest Patents
Zhou's latest patents include innovative compounds and their preparation methods. One notable patent is for an oxazino-quinazoline and oxazino-quinoline type compound, which includes a preparation method and various uses. This compound is particularly significant for its application in creating drugs that act as kinase inhibitors. Another important patent involves urea-substituted aromatic ring-linked dioxinoquinoline compounds. This invention also details a preparation method and highlights its use as a drug for treating disorders related to tyrosine kinase, specifically targeting inhibitors like VEGFR-2, C-RAF, B-RAF, and RET.
Career Highlights
Zhou is currently employed at Beijing Scitech-mq Pharmaceuticals Limited, where he continues to innovate and develop new pharmaceutical compounds. His work is characterized by a strong focus on the therapeutic applications of his inventions.
Collaborations
Zhou collaborates with notable colleagues, including Qiang Zhang and Shannan Yu, who contribute to his research and development efforts.
Conclusion
Likai Zhou's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work has the potential to lead to significant advancements in drug therapies.